Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 1
1965 1
1968 1
1969 1
1971 1
1973 1
1974 1
1975 2
1977 1
1979 1
1982 1
1986 1
1987 2
1988 1
1992 1
1993 3
1996 1
1998 2
1999 1
2000 6
2001 8
2002 3
2003 8
2004 7
2005 11
2006 8
2007 7
2008 8
2009 9
2010 4
2011 7
2012 4
2013 7
2014 15
2015 17
2016 15
2017 11
2018 19
2019 22
2020 25
2021 40
2022 26
2023 38
2024 16

Text availability

Article attribute

Article type

Publication date

Search Results

338 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Tapchom
Page 1
Reply to Ange et al.
Inata Y, Piraino G, Hake PW, O'Connor M, Lahni P, Wolfe V, Schulte C, Moore V, James JM, Zingarelli B. Inata Y, et al. Am J Physiol Heart Circ Physiol. 2019 Apr 1;316(4):H936-H937. doi: 10.1152/ajpheart.00095.2019. Am J Physiol Heart Circ Physiol. 2019. PMID: 30946605 Free article. No abstract available.
Efficacy of maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed, advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Harter P, Mouret-Reynier MA, Pignata S, Cropet C, González-Martín A, Bogner G, Fujiwara K, Vergote I, Colombo N, Nøttrup TJ, Floquet A, El-Balat A, Scambia G, Guerra Alia EM, Fabbro M, Schmalfeldt B, Hardy-Bessard AC, Runnebaum I, Pujade-Lauraine E, Ray-Coquard I. Harter P, et al. Gynecol Oncol. 2022 Feb;164(2):254-264. doi: 10.1016/j.ygyno.2021.12.016. Epub 2021 Dec 22. Gynecol Oncol. 2022. PMID: 34952708 Free article. Clinical Trial.
'Epinephrine-resistant' angioedema.
Ange N, Rabbolini DJ, Pidcock M, Randall KL. Ange N, et al. BMJ Case Rep. 2016 Jan 28;2016:bcr2015213880. doi: 10.1136/bcr-2015-213880. BMJ Case Rep. 2016. PMID: 26823364 Free PMC article.
Un ange passe.
Aebischer G. Aebischer G. Rev Med Suisse. 2023 Apr 26;19(824):834-835. doi: 10.53738/REVMED.2023.19.824.834. Rev Med Suisse. 2023. PMID: 37133950 French. No abstract available.
Towards the Idea of Molecular Brains.
Timsit Y, Grégoire SP. Timsit Y, et al. Int J Mol Sci. 2021 Nov 1;22(21):11868. doi: 10.3390/ijms222111868. Int J Mol Sci. 2021. PMID: 34769300 Free PMC article. Review.
[Humanitarian transition].
Mattei JF, Troit V. Mattei JF, et al. Med Sci (Paris). 2016 Feb;32(2):211-6. doi: 10.1051/medsci/20163202016. Epub 2016 Mar 2. Med Sci (Paris). 2016. PMID: 26936180 Free article. French.
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
Lorusso D, Mouret-Reynier MA, Harter P, Cropet C, Caballero C, Wolfrum-Ristau P, Satoh T, Vergote I, Parma G, Nøttrup TJ, Lebreton C, Fasching PA, Pisano C, Manso L, Bourgeois H, Runnebaum I, Zamagni C, Hardy-Bessard AC, Schnelzer A, Fabbro M, Schmalfeldt B, Berton D, Belau A, Lotz JP, Gropp-Meier M, Gladieff L, Lück HJ, Abadie-Lacourtoisie S, Pujade-Lauraine E, Ray-Coquard I. Lorusso D, et al. Int J Gynecol Cancer. 2024 Apr 1;34(4):550-558. doi: 10.1136/ijgc-2023-004995. Int J Gynecol Cancer. 2024. PMID: 38129136 Free PMC article. Clinical Trial.
338 results